L. Gordon Letts
Nessuna posizione attualmente
Profilo
L.
Gordon Letts is Senior Vice President of Research and Development for Magen BioSciences, Inc. He was Senior Vice President of Research and Development and Chief Scientific Officer for NitroMed.
Prior to his current position, Dr. Letts was Chief Scientific Officer and Senior Vice President of Research and Development for NitroMed.
He was Director of Pharmacology for Boehringer Ingelheim Pharmaceuticals, Senior Research Scientist of Merck Frosst Canada, and Senior Scientist of Royal College of Surgeons of England.
Dr. Letts was President of the International Association of Inflammation.
He has experience in research and development and leadership.
Dr. Letts received a BS degree from Monash University and a PhD from Sydney University.
Precedenti posizioni note di L. Gordon Letts
| Società | Posizione | Fine |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Direttore Tecnico/Scientifico/R&S | 21/05/2007 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/01/1993 |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY. | Amministratore Delegato | - |
Inflammation Research Association, Inc.
 Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Inflammation Research Association, Inc. engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology. The company is headquartered in Newcastle, WA. | Presidente | - |
| Royal College of Surgeons | Direttore Tecnico/Scientifico/R&S | - |
Formazione di L. Gordon Letts
| The University of Sydney | Doctorate Degree |
| Monash University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NETMED, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |
Inflammation Research Association, Inc.
Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Inflammation Research Association, Inc. engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology. The company is headquartered in Newcastle, WA. | Commercial Services |
TargAnox, Inc.
TargAnox, Inc. Pharmaceuticals: MajorHealth Technology TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- L. Gordon Letts
